HUM vs MRNA · P/E 39, rev $129.66B vs rev $1.94B
Humana Inc (HUM) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Latest reported HUM revenue for 2025-12-31 was $129.66B. Net income was $1.19B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported MRNA revenue for 2025-12-31 was $1.94B. Net income was -$2.82B. Revenue was down 39.9% from 2024-12-31 to 2025-12-31. MRNA currently screens at market cap $24.52B.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the HUM and MRNA stock pages for the full models.
Not investment advice.